Multinational specialty bio-pharmaceutical company.
FY 2020 Appropriations - Provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; Reauthorization of the Pandemic and All-Hazards Preparedness Act; NDAA - provisions related to biological and chemical defense; H.R. 2968/S. 2474 - Department of Defense Appropriations re Medical Countermeasures; FDA regulatory issues; Issues related to Priority Review Voucher programs; Issues regarding opioid and heroin addiction legislation, Naloxone access, and co-prescribing/opioid prescribing guidelines; Issues related to FY 2020 Appropriations including: H.R. 3052/S. 2580 - Department of Interior, Environment, and Related Agencies Appropriations Act, 2020; H.R. 2740 - Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020; H.R. 3164/S.2522 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020.
HCR - Health Issues
134 - Centers For Disease Control & Prevention (CDC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 18 - Office of Management & Budget (OMB) 19 - Office of Natl Drug Control Policy (NDCP) 1 - SENATE 141 - Substance Abuse & Mental Health Services Administration (SAMHSA)
FORBES-TATE
777 6th Street NW, 8th Floor, Washington, DC, 20001, US
EDWARD C. RENO DERRICK M WHITE JEFFREY SADOSKY JERRY DRISCOLL ZACHARY WILLIAMS WESLEY RYAN WELCH ELIZABETH GREER RICK MURPHY KRISTINA DUNKLIN